O

Ocugen

D
OCGN
USD
0.0883
(8.9039%)
Market Closed
173,279.00
Volume
-0.17
EPS
-
Div Yield
-6.055556
P/E
310,886,390.52
Market Cap
Today
8.9039%
1 Week
17.891%
1 Month
8.379%
6 Months
-30.769%
12 Months
187.234%
Year To Date
89.474%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
MRNA
MRNA
-0.985
(-1.921%)
USD
B
BNTX
0.99
(0.9269%)
USD
N
NVAX
0.23
(2.5713%)
USD
V
VXRT
-0.0062
(-0.8494%)
USD
A
ALT
0.43
(6.1166%)
USD
I
IMV
0.01
(1.9608%)
USD
A
ADVM
-0.02
(-0.2525%)
USD
V
VAXX
(%)
USD
C
CODX
-0.035
(-2.8926%)
USD
I
INO
-0.18
(-3.1524%)
USD

Title:
Ocugen

Sector:
Healthcare
Industry:
Biotechnology
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Do you need help or have a question?
Contact Us